Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Items 601–700 of 749
Zuo, X., Bai, H., Zhao, Q., Zhao, X., & Feng, X. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00015 · Cited by 3
Early Prediction of Diabetic Macular Edema via Machine Learning Survival Analysis on Checkup Data
Kashiwagi, Y., Chida, K., Hananoe, A., Ishibashi, R., Koshizaka, M., Maezawa, Y., Inaba, Y., Takatsuna, Y., Tatsumi, T., Inoue, H., et al. (2026) · Ophthalmology Science · doi:10.1016/j.xops.2026.101262 · Cited by 1
“36,37 Random survival forest further outperformed Cox models by leveraging population heterogeneity and diverse predictors across decision trees, whereas Cox models assume consistent factor contributions.”
Gouliopoulos, N., Arfara, M., Sapounas, S., ROUVAS, A. A., Theodossiadis, P., Georgalas, I., & Datseris, I. (2026) · HORMONES · doi:10.1007/s42000-026-00816-w · Cited by 1
Zhou, P., Liu, L., & Gao, W. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.03.21 · Cited by 1
Prasad, K. N. (2021) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2021.12.3.0425 · Cited by 1
“Activated retinal microglia migrate to the site of inflammation and produce pro-inflammatory cytokines, ROS, nitric oxide, glutamate , and proteases, which contribute to the degeneration and eventually the death of retinal ganglion cells (43-45).”
BackgroundEffect of circRNA in diabetic retinopathy based on preclinical studies: a systematic review
Lu, Q., Zhang, J., Chen, S. C., Lin, H., Lai, X. M., Gong, W., Wu, Y., & Hu, X. (2021) · All Life · doi:10.1080/26895293.2021.1972347 · Cited by 1
Simó‐Servat, O., Hernández, C., & Simó, R. (2022) · Archives of The Medicine and Case Reports · doi:10.37275/amcr.v3i2.197 · Cited by 1
Diabetic retinopathy, a disease with low-grade inflammation
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00001-9 · Cited by 1
Bioinformatics Tools for Bulk Gene Expression Deconvolution in Diabetic Retinopathy
Teh, R. Q., Liu, G., & Wang, J.-H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3255-0_7 · Cited by 1
Imbarak, N., Korayem, H. E., Soliman, N., & Hosny, S. (2023) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-023-00308-y · Cited by 1
Novitasari, D. C. R., Fatmawati, F., Hendradi, R., Nariswari, R., & Saputra, R. A. (2023) · JOIV International Journal on Informatics Visualization · doi:10.30630/joiv.7.4.01501 · Cited by 2
Al-Nadawi, N. (2023) · Regulatory Mechanisms in Biosystems · doi:10.15421/022377 · Cited by 1
Li, D.-S., Zhang, C.-H., Huang, J., Chen, W., Zhang, J., & Qin, B. (2024) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.04.10 · Cited by 1
“The presence of heightened levels of inflammatory cytokines within the ocular region of patients diagnosed with DME provides evidence to support the notion that inflammation may play a role in the development and progression of DME [10-11] .”
BackgroundKleinschmitt, B. D. A., Tanuri, L. D., dos Santos, M. C. G., dos Santos, M. F. G., & Germani, G. B. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n2-236 · Cited by 2
Morozova, C., Humayun, L. L., Kasper, J. D., Morozov, A., Tabandeh, H., Boyer, D. S., Dayani, P. N., & Rahhal, F. M. (2024) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264241247624 · Cited by 1
Bonnefont‐Rousselot, D. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.08.011 · Cited by 2
Das, N., Rathore, M., & Guha, R. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01422-5 · Cited by 1
“Apelin is a peptide adipokine also expressed ubiquitously in major other tissue functions by binding to G protein-coupled receptor APJ [63].”
Dilek, E. K., Tekin, K., Cankurtaran, V., Dogan, S., & Dirican, E. (2025) · Clinical and Experimental Optometry · doi:10.1080/08164622.2025.2461233 · Cited by 1
“24,26 It has been shown that inflammatory cytokines such as IL-1β, IL-6, IL-8, TNF-α and MCP-1 are elevated in ocular tissues from non-proliferative DR patients.”
A Recent Update on Candidate Biomarkers in the Pathogenesis of Diabetic Retinopathy
Shakthiya, T., Chand, L., & Annamalai, R. (2025) · The Open Biomarkers Journal · doi:10.2174/0118753183372247250213110930 · Cited by 2
Rahimi, A., Moridi, N., & Sajjadi, S. M. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00712-9 · Cited by 1
“The etiology of DR is complex and associated with numerous factors, with several studies indicating the function of inflammatory factors in DR progression [4, 5].”
Daikohara, K., Akanuma, S., Kawanishi, M., Tega, Y., & Hosoya, K. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03872-w · Cited by 1
“In numerous studies, it has been demonstrated that inflammation is a key factor in pathogenesis of DR [4, 5].”
Evaluating TnP as a Potential Therapeutic Agent for Retinopathy in Zebrafish Models
da Rosa, J. G. S., Bernardo, J. T. G., Álvarez, Y., Kennedy, B. N., Lima, C., & Lopes‐Ferreira, M. (2025) · Pharmaceuticals · doi:10.3390/ph18060840 · Cited by 1
Diabetic retinal neuropathy revisited. A perspective after optical coherence tomography angiography
Somilleda-Ventura, S. A., Blanco-Hernández, D. M. R., & Lima-Gómez, V. (2018) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000220 · Cited by 1
“When the amount of these supporting cells of the retinal capillary network, which are part of the inner hemato-retinal barrier [11], decreases considerably, the weakened capillaries bulge to form a microaneurysm [12], the first ophthalmoscopic manifestation of DR.”
BackgroundDeficient Autophagy Contributes to the Development of Diabetic Retinopathy
de Faria, J. M. L., & Dátilo, M. N. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89339 · Cited by 2
Diabetic Retinopathy and Ocular Melanoma: How Far We Are?
Souto, E. B., Campos, J. R. S., da Ana, R., Fangueiro, J. F., Martins‐Gomes, C., Durazzo, A., Lucarini, M., Sánchez‐López, E., Espina, M., García, M. L., et al. (2020) · Applied Sciences · doi:10.3390/app10082777 · Cited by 1
“Advances have been made to treat vascular changes, but there is no therapy yet for early neuro-glial disorders in DR [5].”
BackgroundInfluentialHe, G., Zhou, J., & Yang, X. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-1898 · Cited by 1
“Longterm effusion changes can increase the pressure on the blood vessel wall, making the blood vessel wall thinner and prone to proliferative lesions (7).”
BackgroundGül, F. C., Çelik, F., Aydın, S., & Akkoç, R. F. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.03.13 · Cited by 1
Advances in the Pathogenesis of Diabetic Macular Edema
王, 娟. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125719 · Cited by 1
Fitrada, L., Ratnaningsih, N., & Iskandar, E. (2022) · International Journal of Retina · doi:10.35479/ijretina.2022.vol005.iss002.199 · Cited by 1
Prihanto, E. S. D., Yetrina, Y., Syah, M. S. F., & Imbar, A. W. J. (2022) · Jurnal Health Sains · doi:10.46799/jhs.v3i12.698 · Cited by 3
EDITORIAL: Special issue on the role of lipid and protein oxidation in retinal degenerations
Fliesler, S. J., & Ferrington, D. A. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.03.010 · Cited by 1
Pathogenesis of diabetic macular edema
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00003-2 · Cited by 1
Mu, P., Tang, X., Tan, Y. C. R. S., Wang, Y., Lin, S., Wang, M., Shu, J., Wang, J., Zhang, Y., Liang, H., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12928
“The findings of the present study suggest that BOT is superior to OADs alone as a subsequent therapy to prevent or delay DR, which implies that basal insulin supplementation benefited DR.”
BackgroundInfluentialFEATURES OF CELL IMMUNITY IN PATIENTS WITH DIABETIC RETINOPATHY
Horecha, M. Y., Lapovets, L. Y., Акімова, В. М., Lapovets, N. Y., & Tsymbala, O. P. (2020) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2020-2-156-96-98
Shabrina, D., Fakrurizal, I., & Putra, A. B. (2019) · Al-Iqra Medical Journal Jurnal Berkala Ilmiah Kedokteran · doi:10.26618/aimj.v3i1.2747
Sun, W., Li, C., Gao, H., & Miao, J. (2020) · doi:10.22541/au.158274529.91358605
Vorobyeva, I. V., Moshetova, L. K., Пинчук, А. В., Bulava, E. V., Delver, E. P., & Aa, B. (2021) · Russian Journal of Clinical Ophthalmology · doi:10.32364/2311-7729-2021-21-2-90-95
“…Articles шающее значение в патогенезе ДР, поскольку оно может вызывать нейрососудистое повреждение и стимулировать ишемическую неоваскуляризацию [19]. п атогенез дИабетИческой нефропатИИ ДН является ведущей причиной ТПН и, по-видимому, возникает в результате взаимодействия воспалительных,…”
Mechanistic Insights into Immunological Therapy for Targeting Diabetic Retinopathy
Qamar, I. (2021) · Endocrinology and Disorders · doi:10.31579/2640-1045/073
Zhang, X., Wang, L., Huang, X., & Zheng, Y. (2020) · doi:10.21203/rs.3.rs-37961/v1
Simonsen, J. R. (2021) · Helda - University of Helsinki Institutional Repository
Commentary: Oral management of diabetic retinopathy
Delhiwala, K., & Khamar, B. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2088_21
“[5-7] Recently, intravitreal anti-VEGF treatment has also been shown to delay the progression of non-proliferative DR to proliferative DR.[8] In diabetic animals, control of inflammation by systemic therapy was found to be associated with amelioration of DR.[9] However, this has not been evaluated in humans.”
BackgroundInfluentialDiagnosis and Management of Ophthalmic Complications of Diabetes
Barkmeier, A. J., & Astafurov, K. V. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch21
Modulation of inflammatory pathway by inflammatory inhibitor JSH-33 mitigates diabetic retinopathy.
Homme, R. P. (2020) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3479
Pathogenesis of Microvascular Complications
Shore, A. C. (2022) · doi:10.1093/med/9780198870197.003.0275 · Cited by 1
Rodrigues, L. T. D. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11042022-132330 · Cited by 1
Pietrzak-Nowacka, M., Lejkowska, R., Kawa, M. P., Ulańczyk, Z., Safranow, K., Nowacka, B., Podborączyńska‐Jodko, K., Lubiński, W., Ciechanowski, K., Machaliński, B., et al. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0001
“Using high-speed confocal Ca2+ imaging, it has been demonstrated that the resulting signals are far from homogeneous, with spontaneous activity in retinal arterioles being characterized by both localized Ca2+ sparks and more global Ca2+ waves and oscillations [39, 40, 41].”
BackgroundTh22 Cells Induce Müller Cells Activation Via the Act1/Traf6 Pathway in Diabetic RetinopathyPreprint
Wang, Y., Yu, H., Li, J., Liu, W., Yu, S., Lv, P., Zhao, L., Wang, X., Zuo, Z., & Liu, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4092955
Cheng, H., xu, L., Bu, R., jiang, C., yao, L., & Wu, W. (2020) · Research Square · doi:10.21203/rs.2.22522/v1
“have been established the contribution to the inflammatory response[5,9,10].”
BackgroundKhalid, M., Patel, H., Syed, S., & Lakhi, S. (2022) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.303
Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic retinopathy
Majeed, N. S., Al-Ani, M. Q., & Alsabti, Z. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.9640
Application Value of Neutrophil to Lymphocyte Ratio in Diabetic Retinopathy
易, 静. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125548
Pietrzak-Nowacka, M., Lejkowska, R., Kawa, M. P., Ulańczyk, Z., Safranow, K., Nowacka, B., Podborączyńska‐Jodko, K., Lubiński, W., Ciechanowski, K., Machaliński, B., et al. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0043
Ophthalmological Metabolic Diseases and Stem Cells
Zúñiga-Gazcón, H., Delgado, M. A. F., Mayorga, D. E. S., Calderón, L. A. V., & Ramírez, M. H. G. (2022) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v2-i7-15
The effect of type 2 diabetes mellitus on the retinaPreprint
Tabaa, K., & Hammoud, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2110260/v1
The role of micro-RNA (miRNA) 126 on diabetic macular edema. Literature review
Sasono, W., Nurwasis, N., Aryati, Yustiarini, I., & Suhendro, G. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.3.8
Association of serum homocysteine with type II diabetic retinopathy.
Junaid, S., Rehman, S., Moazzam, H., Yosuf, I., Gohar, L., & Saddiqa, I. (2022) · The Professional Medical Journal · doi:10.29309/tpmj/2022.29.11.7196
Inflammasomes in the pathobiology of degenerative retinopathies
Silke, E., Cahill, M. T., Campbell, M., & Doyle, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00021-9 · Cited by 1
Association of Proliferative Diabetic Retinopathy in the Elderly with the Blood Complement System
Фабрикантов, О. Л., Агарков, Н. М., Лев, И. В., Станиславовна, Г. Т., & Иванович, Н. С. (2023) · Ophthalmology in Russia · doi:10.18008/1816-5095-2022-4-829-834
The Role of Cytokines in the Pathogenesis of Diabetic Macular Edema
高, 春. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133689
Actualización en Oft�almología Tomo 3
Rodríguez, A. A. V., Yandún, G. D. P., Barros, L. V. G., Naranjo, J. S. P., Párraga, E. J. V., Guacho, M. J. S., Carrasco, P. A. C., & Mendoza, C. A. G. (2023) · Juan Cuevas eBooks · doi:10.56470/978-9942-627-25-4
Future perspectives for diabetic retinopathy management
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00006-8
Diabetic retinopathy, a neurovascular unit disease
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00005-6
Neurodegeneration and microangiopathy in diabetic retina and choroid
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00010-x
Actualización en Oftalmología Tomo 5
Estupiñan, A. S. U., Armijos, I. V. C., Tacoamán, O. I. Z., Sánchez, M. C. P., & Figueroa, G. R. S. (2023) · Juan Cuevas eBooks · doi:10.56470/978-9942-650-18-4
Jin, Z., Zhang, Q., Liu, K., Wang, S., Yan, Y., Zhang, B., Zhao, L., & Tong, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4578566
Ardyansyah, M. A., & Gunawansyah, G. (2023) · Jurnal Teknologi Terapan G-Tech · doi:10.33379/gtech.v7i4.3332
Cholesterol Crystals in Diabetic Retinopathy
Shihab, Y. A., Adu-Agyeiwaah, Y., Dorweiler, T. F., Pikuleva, I. A., Busik, J. V., & Grant, M. B. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_20
Eichenbaum, D. A., González, V. H., Roth, D. B., Fortun, J. A., Radcliffe, N. M., Cutino, A., Kasper, J. D., Coughlin, B., & Arévalo, J. F. (2024) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20231109-02
Treatment of diabetic macular edema: Bibliometric analysisPreprint
Wang, S., Shen, W., Wang, W., Xin, S., Ren, W., & Jin, K. (2024) · Research Square · doi:10.21203/rs.3.rs-3848475/v1
Vodianyk, V. V., & Ziablitsev, S. V. (2023) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.4.2023.15 · Cited by 1
Dharma, A. G., Wildan, A., Maharani, M., Prihatningtias, R., Rahmi, F. L., Nugroho, T., Saubig, A. N., & Rikiandraswida, Z. (2024) · World Nutrition Journal · doi:10.25220/wnj.v07.i2.0004
“In the pathogenesis of diabetic retinopathy, oxidative stress and mitochondrial dysfunction initiate the development of the characteristic histopathology of DR. 1,24 High homocysteine can damage mitochondria, accelerate capillary cell apoptosis, and the progression of diabetic retinopathy.”
BackgroundIntravitreal injection of methotrexate in persistent diabetic macular edema: a 6-month study
Razzaghpour, N., Najafi, A., Sabouri, M. R., Ashoori, N., & Shahraki, K. (2023) · Medical Hypothesis Discovery & Innovation in Ophthalmology · doi:10.51329/mehdiophthal1480
Cyrino, F. V. R. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-08022024-164925
Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya
Emgory, T., & Gibril, A. (2024) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.2472024
“…study found no significant differences in retinal metrics between healthy controls, glaucoma patients, and those with both glaucoma and diabetes [37–39] The study found a positive correlation between glaucoma duration and cup-to-disc ratio [CDR], indicating an increase in CDR as the disease…”
BackgroundZiablitsev, S. V., & Zhupan, D. B. (2024) · Oftalmologicheskii Zhurnal · doi:10.31288/oftalmolzh202433339
Novitasari, D. C. R., Fatmawati, F., Hendradi, R., Nariswari, R., & Saputra, R. A. (2023) · JOIV International Journal on Informatics Visualization · doi:10.62527/joiv.7.4.1501 · Cited by 1
Sudhakaran, G. (2024) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2024.2377736
Ge, P., Jiang, T., Zong, Y., Lu, S., Yang, X., Xu, X., Fan, X., Song, L., Yang, Y., & Sun, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4682079/v1
Darwisch, W., Waizel, M. D. V., Roberts, P. K., Boden, K., Szurman, P., & Rickmann, A. (2024) · Ophthalmic Research · doi:10.1159/000540459
The Role of Müller Cells in Diabetic Retinopathy
Açan, D. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006382 · Cited by 1
Targeting long non-coding RNA RP11-502I4.3 delays the trend of angiogenesis in diabetic retinopathyPreprint
Zeng, L., Wu, Y., Zhu, L., He, J., Yuan, Y., Wang, X., Tang, K., & Tan, W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.15.618482
Liu, X., Fang, J., Niu, T., Xing, X., Shi, X., Xiao, Y., Qu, Y., Jiang, Y., Lv, K., Dou, T., et al. (2024) · Journal of Diabetes Research · doi:10.1155/jdr/5513165
Diabetische Retinopathie und diabetisches Makulaödem
Ziemssen, F., & Gelişken, F. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-65929-8_44-1
Comparison of the Effects of the Ketogenic Diet and Western Diet on the Retina in Rats with Diabetes
Sönmezoğlu, H. İ., Yuvacı, İ., Cengiz, N., Sönmezoğlu, B. G., OTURAK, G., & Çelik, E. (2024) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.1502084
Yin, D., Luo, X., Wei, M., Tang, Y., Jiang, Y., Wang, C., Li, A., Guo, J., & Gong, Y. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303358069241213151650 · Cited by 1
Mechanisms of early diabetic retinopathy development (experimental study)
Usenko, K. O. (2025) · Archive of Ukrainian Ophthalmology · doi:10.22141/2309-8147.12.3.2024.393
Usenko, K. O. (2025) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.1.2025.08
Attya, M., Taha, A., Eldin, S. A. G., El-Essawy, R. A., & Mohalhal, A. A. (2025) · European Journal of Ophthalmology · doi:10.1177/11206721251332791
Diabetische Retinopathie und diabetisches Makulaödem
Ziemssen, F., & Gelişken, F. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65823-9_44
Hossain, B., Rahmatullah, S., & Ahmed, T. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003363
“Given that DME is inherently an inflammatory condition, there has been speculation that IOI might occur more frequently in these patient [ 33 ] .”
Niema, E., Albaghlany, R. M., & Mansor, A. (2025) · International Journal of Health Sciences · doi:10.53730/ijhs.v9n2.15655
“These facts indicate that endothelial dysfunction is related to multiple diabetes-linked issues, like retinopathy, nephropathy, and atherosclerosis, which notably increase the risk of CVD (Rübsam et al., 2018).”
Retinal Fundus Image Classification Using Generative Adversarial Networks
Dutta, M., Khan, M. A. A., Rabbi, M. M. F., Rahman, M. A., & Islam, M. M. (2025) · International Conference on Electrical, Computer and Communication Engineering · doi:10.1109/ecce64574.2025.11013430
“DR alone affects over 93 million people [2].”
Smart Materials in Ophthalmic Applications
Jimenez, J., Phelps, E., & DiLeo, M. V. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781839169779-00419
Efektivitas Senyawa Kurkumin pada Kunyit (Curcuma longa) terhadap Pencegahan Retinopati Diabetik
Shafiyah, F. (2025) · Surabaya Biomedical Journal · doi:10.30649/v4i3.105
Naskar, A., Mukherjee, S., Samajdar, S. S., Chatterjee, R., Bhadra, T. R., & Jana, K. (2025) · Bengal Physician Journal · doi:10.5005/jp-journals-10070-8060
Éléments de physiopathogénie de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00002-7
Peng, Y., Toh, H., Clegg, D., & Jiang, P. (2025) · Biomedicines · doi:10.3390/biomedicines13081926
Dong, L., Xue, C., Gao, J., Hu, Y., Kang, Z., Sun, A., Li, J.-R., Tong, X., Wang, X.-G., & Li, X. (2025) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-025-3938-2 · Cited by 1
Ambra1 Deficiency Improves Retinal Inflammation in Streptozotocin-Induced Diabetic Mouse Models
Suzuki, T., Sato, T., Masuhara, K., Tokusanai, M., Akatsuka, H., & Kashikawa, T. (2025) · Cureus · doi:10.7759/cureus.90937
“In diabetic retina, Müller glial cell activation is induced by enhanced inflammatory responses [20].”
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.